HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dennis C Sgroi Selected Research

Paraffin

1/2016Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study.
10/2006The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dennis C Sgroi Research Topics

Disease

46Neoplasms (Cancer)
10/2021 - 07/2002
44Breast Neoplasms (Breast Cancer)
01/2022 - 11/2002
5Carcinogenesis
01/2021 - 12/2005
3Neoplasm Metastasis (Metastasis)
01/2021 - 12/2006
3Ductal Carcinoma
01/2019 - 05/2004
3Endometrial Neoplasms (Endometrial Cancer)
11/2014 - 03/2011
2Noninfiltrating Intraductal Carcinoma (DCIS)
01/2014 - 11/2002
2Triple Negative Breast Neoplasms
06/2012 - 03/2010
2Lung Neoplasms (Lung Cancer)
11/2011 - 07/2006
2Adenocarcinoma
07/2006 - 11/2005
2Hyperglycemia
03/2002 - 02/2002
1Lobular Carcinoma
10/2021
1Rhabdomyosarcoma
01/2019
1Brain Neoplasms (Brain Tumor)
03/2014
1Chromosomal Instability (Chromosome Stability)
01/2014
1Prostatic Neoplasms (Prostate Cancer)
11/2011
1Colonic Neoplasms (Colon Cancer)
11/2011
1Glioma (Gliomas)
11/2011
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2011
1Hypersensitivity (Allergy)
08/2011
1Aneuploidy (Aneuploid)
08/2011
1Genomic Instability
08/2011
1Type 2 Diabetes Mellitus (MODY)
07/2010
1Dehydration (Water Stress)
01/2009
1Hypoxia (Hypoxemia)
03/2008
1Ovarian Neoplasms (Ovarian Cancer)
10/2007
1Disease Progression
10/2007
1Pancreatic Neoplasms (Pancreatic Cancer)
07/2006
1Stomach Neoplasms (Stomach Cancer)
02/2006
1Oncogene Addiction
02/2006
1Head and Neck Neoplasms (Head and Neck Cancer)
11/2005

Drug/Important Bio-Agent (IBA)

17Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2007
17TamoxifenFDA LinkGeneric
01/2022 - 06/2004
15Estrogen ReceptorsIBA
01/2017 - 06/2004
14Proteins (Proteins, Gene)FDA Link
09/2017 - 11/2002
9Hormones (Hormone)IBA
01/2022 - 06/2004
72- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA
01/2022 - 03/2013
7Biological ProductsIBA
03/2014 - 11/2005
6Phosphotransferases (Kinase)IBA
01/2018 - 05/2005
6Progesterone Receptors (Progesterone Receptor)IBA
05/2014 - 10/2006
4DNA (Deoxyribonucleic Acid)IBA
01/2019 - 05/2003
4ErbB Receptors (EGF Receptor)IBA
03/2014 - 11/2005
3Estrogens (Estrogen)FDA Link
01/2018 - 11/2007
3Transcription Factors (Transcription Factor)IBA
01/2011 - 12/2005
3Gefitinib (Iressa)FDA Link
07/2006 - 11/2005
3Tyrosine Kinase InhibitorsIBA
07/2006 - 11/2005
3Messenger RNA (mRNA)IBA
12/2005 - 02/2002
2Neoplasm Antigens (Tumor Antigens)IBA
01/2021 - 01/2014
2LigandsIBA
01/2021 - 08/2008
2Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2019 - 03/2014
2Temozolomide (Temodar)FDA LinkGeneric
01/2019 - 03/2014
2Formaldehyde (Formol)FDA Link
01/2016 - 10/2006
2ParaffinIBA
01/2016 - 10/2006
2Tyrosine (L-Tyrosine)FDA Link
11/2014 - 01/2006
2Erlotinib Hydrochloride (CP 358,774)FDA Link
05/2014 - 07/2006
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
03/2014 - 06/2012
2Interleukin-17 (Interleukin 17)IBA
09/2008 - 04/2006
2Growth Factor ReceptorsIBA
04/2006 - 02/2006
2Pharmaceutical PreparationsIBA
02/2006 - 01/2006
2Fatty Acids (Saturated Fatty Acids)IBA
11/2002 - 03/2002
2PhlorhizinIBA
03/2002 - 02/2002
1CarcinogensIBA
01/2021
1anthraceneIBA
01/2021
1CC ChemokinesIBA
01/2021
1olaparibIBA
01/2019
1PhosphoproteinsIBA
01/2018
1RNA (Ribonucleic Acid)IBA
01/2016
1Octreotide (Sandostatin)FDA LinkGeneric
01/2016
1GTP-Binding Proteins (G-Protein)IBA
05/2014
1NucleotidesIBA
01/2014
1Anastrozole (Arimidex)FDA LinkGeneric
10/2013
1Ligases (Synthetase)IBA
12/2012
1UbiquitinIBA
12/2012
1p38 Mitogen-Activated Protein KinasesIBA
06/2012
1Tumor Biomarkers (Tumor Markers)IBA
11/2011
1Nonsense Codon (Nonsense Mutation)IBA
08/2011
1Proliferating Cell Nuclear Antigen (PCNA)IBA
08/2011
1Fulvestrant (Faslodex)FDA Link
01/2011
1ProteomeIBA
11/2010
1Cisplatin (Platino)FDA LinkGeneric
03/2010
1A-Form DNA (A-DNA)IBA
03/2010
1Ribosomal Proteins (Ribosomal Protein)IBA
01/2009
1Metalloproteases (Metalloproteinases)IBA
01/2009
1Cytochrome P-450 CYP2D6 (CYP2D6)IBA
09/2008
1Cysteine (L-Cysteine)FDA Link
08/2008
1Peptides (Polypeptides)IBA
08/2008
1ChemokinesIBA
03/2008
1Estradiol (Delestrogen)FDA LinkGeneric
11/2007
1Transforming Growth Factor beta (TGF-beta)IBA
12/2006
1Capecitabine (Xeloda)FDA Link
07/2006
15- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA
02/2006
1Protein Isoforms (Isoforms)IBA
01/2006
1Proto-Oncogene Proteins c-etsIBA
12/2005

Therapy/Procedure

15Therapeutics
01/2022 - 05/2005
13Lasers (Laser)
03/2014 - 07/2002
2Adjuvant Chemotherapy
03/2013 - 05/2008
2Molecular Targeted Therapy
02/2006 - 05/2005
1Cell Transplantation
01/2019
1Drug Therapy (Chemotherapy)
12/2017
1Complementary Therapies (Alternative Medicine)
04/2006